{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-016626","form_type":"8-K","ticker":"AHCO","cik":"0001725255","company_name":"AdaptHealth Corp.","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.252667+00:00","generated_at":"2026-06-15T09:32:46.823982+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AdaptHealth Q1 revenue +5.4% to $744.6M; adjusted EBITDA -2.7% to $134M","bullets":["Net revenue $744.6M, up 5.4% YoY; non-acquired growth 4.7%.","Adjusted EBITDA $134.0M, down 2.7% from $137.6M in Q1 2022.","Sleep category revenue grew 17.6% YoY; Diabetes business declined.","Net income attributable to AdaptHealth Corp. was $15.7M.","Company launched cost management program to revamp supply chain and real estate."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-016626","json":"https://secwatch.observer/filing/0001628280-23-016626.json","markdown":"https://secwatch.observer/filing/0001628280-23-016626.md","text":"https://secwatch.observer/filing/0001628280-23-016626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023016626/0001628280-23-016626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023016626/ahco-20230509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T09:32:46.823982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4db848a87111a2eea3e466858567c7e0f34ad79f","claim":"AdaptHealth Corp. reported first quarter ended March 31, 2023 results: revenue Net revenue was $744.6 million, net income Net income attributable to AdaptHealth Corp. was $15.7 million.","evidence_excerpt":"medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2023. First Quarter Results and Highlights • Net revenue was $744.6 million compared to $706.2 million in the first quarter of 2022, an increase of 5.4%, including 17.6% growth in our Sleep categories. • Non-acquired growth was 4.7%. • Net income","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023016626/0001628280-23-016626-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"Net revenue was $744.6 million"},{"label":"Net income","value":"Net income attributable to AdaptHealth Corp. was $15.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}